0000950170-24-025992.txt : 20240305
0000950170-24-025992.hdr.sgml : 20240305
20240305162431
ACCESSION NUMBER: 0000950170-24-025992
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dulac Edward J III
CENTRAL INDEX KEY: 0001821530
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 24720861
MAIL ADDRESS:
STREET 1: FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 651311552
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
4
1
ownership.xml
4
X0508
4
2024-03-04
0001434316
FATE THERAPEUTICS INC
FATE
0001821530
Dulac Edward J III
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO
CA
92131
false
true
false
false
Chief Financial Officer
true
Common Stock
2024-03-04
4
S
false
2447
7.77
D
101479
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 5, 2023.
/s/ Cindy Tahl, as Attorney-in-Fact
2024-03-05